| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081203 Methods for treating lymphomas in certain patient populations and screening patients for said therapy |
| 03/26/2009 | US20090081202 Immunogenic compositions and methods |
| 03/26/2009 | US20090081201 Methods for Identifying Compounds For the Treatment of Type 1 Diabetes |
| 03/26/2009 | US20090081200 Tissue Factor Antibodies and Uses Thereof |
| 03/26/2009 | US20090081199 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/26/2009 | US20090081198 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 03/26/2009 | US20090081197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity |
| 03/26/2009 | US20090081196 Medicaments for fungal infections |
| 03/26/2009 | US20090081195 Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility |
| 03/26/2009 | US20090081194 Compositions and methods for reducing risk of development, or severity, of inappropriate immune response in eyes |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081192 Methods of screening for compounds having anti-inflammatory activity |
| 03/26/2009 | US20090081191 Immunoglobulins; epithelial cell adhesion molecule (EpCAM) |
| 03/26/2009 | US20090081190 Methods for Antibody Library Screening |
| 03/26/2009 | US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081177 Methods and compositions for improving pregnancy outcome |
| 03/26/2009 | US20090081157 Immunostimulatory Combinations for Vaccine Adjuvants |
| 03/26/2009 | US20090081156 Bioactive molecular matrix and methods of use in the treatment of disease |
| 03/26/2009 | US20090081155 Use of Inhibitors of Indoleamine-2,3-Dioxygenase in Combination with Other Therapeutic Modalities |
| 03/26/2009 | US20090081139 Water-based delivery systems |
| 03/26/2009 | US20090081133 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081127 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
| 03/26/2009 | CA2705306A1 Neoepitope detection of disease using protein arrays |
| 03/26/2009 | CA2700276A1 Inhibition of angiogenesis |
| 03/26/2009 | CA2700128A1 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 03/26/2009 | CA2700047A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 03/26/2009 | CA2699756A1 Vaccine composition for the prevention of cmv infection |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/26/2009 | CA2698667A1 Human gm-csf antigen binding proteins |
| 03/26/2009 | CA2698397A1 Method of conferring a protective immune response to norovirus |
| 03/26/2009 | CA2697896A1 Ctl inducer composition |
| 03/26/2009 | CA2696634A1 Monoclonal antibodies against human acidic and basic ferritins and nucleotide and amino acid sequences thereof |
| 03/25/2009 | EP2039773A1 Mutant vesicular stomatitis viruses and use thereof |
| 03/25/2009 | EP2039766A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039704A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/25/2009 | EP2039703A1 Toxin detection method |
| 03/25/2009 | EP2039369A1 Treatment of fungal infections |
| 03/25/2009 | EP2039368A2 Methods for preventing reactivation of latent virus and controlling virus replication |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039251A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 03/25/2009 | EP2038417A2 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 03/25/2009 | EP2038306A1 Anti-nkg2a antibodies and uses thereof |
| 03/25/2009 | EP2038305A1 Antibody molecules which bind human il-17 |
| 03/25/2009 | EP2038297A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 03/25/2009 | EP2037963A2 Soft tissue repair and regeneration using stem cell products |
| 03/25/2009 | EP2037961A2 Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity |
| 03/25/2009 | EP2037960A2 Methods for manipulating stem cells |
| 03/25/2009 | EP2037959A2 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 03/25/2009 | EP2037958A2 A hybrid cell vaccine against leishmaniasis [kala-azar] |
| 03/25/2009 | EP2037957A2 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| 03/25/2009 | EP1767626B1 Peroral vaccine carrier system |
| 03/25/2009 | EP1706423B1 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 03/25/2009 | EP1594536B1 Adjuvanted influenza vaccine |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | EP1250593B1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs) |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | EP1053010B1 Copolymer compositions for oral delivery |
| 03/25/2009 | CN101395265A Mycobacterial SecA2 mutants |
| 03/25/2009 | CN101395183A Anti-ephb4 antibodies and methods using same |
| 03/25/2009 | CN101395182A Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 03/25/2009 | CN101395176A Peptide sequences and compositions |
| 03/25/2009 | CN101395175A Chicken virus vaccine and diagnostic |
| 03/25/2009 | CN101395174A Hpv antigens, vaccine compositions, and related methods |
| 03/25/2009 | CN101394868A Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 03/25/2009 | CN101394865A Compositions and methods relating to treatment of cancer and infectious diseases |
| 03/25/2009 | CN101394864A Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 03/25/2009 | CN101392261A Modified highly pathogenic porcine reproductive and respiratory syndrome virus ORF5 gene and application |
| 03/25/2009 | CN101392239A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 03/25/2009 | CN101392232A Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine |
| 03/25/2009 | CN101392021A Protective antigen composition capable of excitating organism to generate immunity against plague and use thereof |
| 03/25/2009 | CN101391102A Production technique of immunoglobulin compounding agent capable of preventing and treating poultry respiratory disease |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/25/2009 | CN100471948C Composition of antibody specifically binding to CD20 |
| 03/25/2009 | CN100471945C Novel avian disease bacteria and bacterin derived therefrom |
| 03/25/2009 | CN100471872C Optimizing fusion protein containing VEGF recerver segment and medical application thereof |
| 03/25/2009 | CN100471871C Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/25/2009 | CN100471486C Immunomodulatory compositions, methods of making, and methods of use thereof |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507802 inducing immune activation of T-helper 1 type; anti-cancer treatments; bacteria is Escherichia coli or mycobacteria; synergistic mixture |
| 03/24/2009 | US7507797 Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 03/24/2009 | US7507796 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507724 capable of enhancing efficacy of vaccines; capable of enhancing the action of an agent in preventing tissue rejection |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507704 Receptor modulated cancer protocols |
| 03/24/2009 | US7507703 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 03/24/2009 | US7507564 Tiacumicin production |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507538 Human papilloma virus immunoreactive peptides |